Research
Adjunctive L-Methylfolate Tied to Executive Function Gains in Psychiatric Patients
The Brief
- In treatment-experienced psychiatric patients on established pharmacotherapy, adjunctive L-methylfolate (Deplin) was linked with significant reductions in overall symptom burden.
- The same association was reported for improvements in executive function.
- The reported findings are associations, and the source excerpt does not describe study design or sample size.
Why it matters
The report links an add-on to standard psychiatric medication with symptom and executive function changes, which may inform clinical discussions about adjunctive treatment, though the evidence described is associational.
Who’s affected
- Clinicians treating treatment-experienced psychiatric patients
- #l-methylfolate
- #psychiatry
- #executive-function
- #adjunctive-therapy
- #clinical-research
(MedPage Today) -- In treatment-experienced psychiatric patients receiving established pharmacotherapy, adjunctive L-methylfolate (Deplin) was linked with significant reductions in overall symptom burden and improvements in executive function...